EHC — Encompass Health Income Statement
0.000.00%
Last trade - 00:00
- $9.38bn
- $12.64bn
- $4.80bn
- 98
- 32
- 97
- 89
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,605 | 3,566 | 4,015 | 4,349 | 4,801 |
Cost of Revenue | |||||
Gross Profit | 4,437 | 3,395 | 3,831 | 4,147 | 4,583 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,920 | 3,041 | 3,357 | 3,720 | 4,069 |
Operating Profit | 685 | 525 | 658 | 629 | 732 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 562 | 353 | 505 | 451 | 607 |
Provision for Income Taxes | |||||
Net Income After Taxes | 446 | 278 | 403 | 351 | 475 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 359 | 284 | 412 | 271 | 352 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 359 | 284 | 412 | 270 | 350 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.63 | 2.08 | 3.01 | 2.6 | 3.65 |
Dividends per Share |